drugset / Trial / NCT07645235
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Women
Phase 1
Recruiting
8 enrolled
GlaxoSmithKline
Biomedical Advanced Research and Development Authority · collab
NaSingle-groupOpen-labelTreatment
Summary
This study aims to evaluate the pharmacokinetic of gepotidacin in fed healthy lactating women.
Timeline
- Start
- 2026-07-23
- Primary completion
- 2027-05-17
- Completion
- 2027-05-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gepotidacin | Small molecule | 3000 mg | Oral |